You are here

ertugliflozin

Merck, Pfizer trot out more support for latecomer SGLT2 candidate ertugliflozin

Fierce Pharma

Sun, 06/11/17 - 09:24 am

3 Tremendously Promising Diabetes Drugs Potentially on the Way

Motley Fool

Sun, 03/26/17 - 12:02 pm

Lexicon Pharmaceuticals

Merck and Pfizer prep for battle with SGLT2, combo diabetes filings

Fierce Pharma

Mon, 03/13/17 - 10:18 am

SGLT2 inhibitor

Boehringer Ingelheim

Merck, Pfizer line up a big FDA decision on a blockbuster hopeful, staring down some major league competition

Endpoints

Tue, 03/7/17 - 11:55 am

type 2 diabetes

Merck and Pfizer's diabetes treatment meets primary endpoint of late-stage trial

Marketwatch

Thu, 09/15/16 - 09:50 am

clinical trials

Recent Corporate and Pipeline Developments for Pfizer

Market Realist

Mon, 08/15/16 - 11:07 am

Bamboo Therapeutics

Western Oncolytics

Merck, Pfizer expand trial studying CV benefit of experimental diabetes drug

BioPharma Dive

Wed, 06/15/16 - 11:11 pm

clinical trials

Merck, Pfizer Double Size of Diabetes Drug Study to Catch Rivals

Bloomberg

Sun, 06/12/16 - 12:25 pm

clinical trials

The 2013 Merck-Pfizer Diabetes Deal Now Looks Very Savvy

Forbes

Thu, 08/20/15 - 03:14 pm

Merck's Diabetes Pipeline Candidates Are Sure Bets; Only A Matter Of When

Seeking Alpha

Fri, 12/26/14 - 10:18 pm

What The Pfizer-Merck Diabetes Deal Teaches About Today's Pharma R&D

Forbes

Tue, 04/30/13 - 08:15 am

Lexicon Pharma Falls on Concerns Raised by Merck-Pfizer Diabetes Partnership

TheStreet.com

Mon, 04/29/13 - 11:48 am

Lexicon Pharmaceuticals

Merck, Pfizer to jointly develop diabetes drug

Reuters

Mon, 04/29/13 - 10:48 am